Finally, p53 loss increased tolerance of pharmacological perturbation of mitosis using an inhibitor of CENP-E, further supporting its potential role in the development of CIN in HGSOC. This evidence concerns the gene TP53 and cervical squamous intraepithelial neoplasia.